41 results
Page 2 of 3
8-K
EX-99.1
jjctm ojop9pnn
3 May 21
Karyopharm Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress
7:20am
8-K
EX-3.1
i7b6f6wb9gggw zouogw
17 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
PRE 14A
mwzv4rb7dfv
2 Apr 19
Preliminary proxy
4:29pm
POS AM
lczgy
28 Feb 19
Prospectus update (post-effective amendment)
4:54pm
POSASR
h5mk3s3tav5k
28 Feb 19
Automatic shelf registration (post-effective amendment)
4:17pm
424B5
8rsg5b9fc
17 Aug 18
Prospectus supplement for primary offering
4:05pm
S-3ASR
n97btotkrtdau9
2 Jul 18
Automatic shelf registration
4:08pm
424B5
p6sgj 5gc
26 Apr 17
Prospectus supplement for primary offering
12:00am
424B5
rzucuxy6ahvkkvmp
24 Apr 17
Prospectus supplement for primary offering
12:00am